CITIC Securities Co., Ltd.(CIIHY)
Search documents
湖南发展购买四家水电公司控股权获通过 中信证券建功
Zhong Guo Jing Ji Wang· 2026-02-08 08:16
重组委会议现场问询的主要问题: 请上市公司代表结合控股股东尚未注入的水力发电业务经营业绩、光伏发电业务代为培育的进展、控股 股东关于避免同业竞争的承诺及履行情况,说明同业竞争后续解决措施及其可行性。请独立财务顾问代 表、律师代表发表明确意见。 无。 湖南发展表示,本次交易尚需取得中国证券监督管理委员会同意注册的批复,最终能否取得中国证券监 督管理委员会同意注册的批复及最终取得时间仍存在不确定性。公司将根据本次交易的进展情况,严格 按照有关法律法规的规定及时履行信息披露义务。 根据湖南发展于2026年1月30日披露的发行股份及支付现金购买资产并募集配套资金暨关联交易报告书 (草案)(上会稿),上市公司拟以发行股份及支付现金的方式购买电投公司持有的铜湾水电90%股权、清 水塘水电90%股权、筱溪水电88%股权及高滩水电85%股权。同时,上市公司拟向不超过35名符合条件 的特定投资者发行股份募集配套资金 中国经济网北京2月8日讯深圳证券交易所并购重组审核委员会2026年第3次审议会议于2026年2月6日召 开,审议结果显示,湖南能源集团发展股份有限公司(证券简称:湖南发展(000722),证券代码: 000722) ...
珂玛科技不超7.5亿元可转债获深交所通过 中信证券建功
Zhong Guo Jing Ji Wang· 2026-02-07 06:55
Core Viewpoint - Kema Technology (301611.SZ) has received approval from the Shenzhen Stock Exchange's Listing Review Committee for its application to issue convertible bonds to unspecified objects, with a total fundraising target of up to RMB 75 million [1][2]. Group 1: Issuance Details - The issuance application was reviewed on February 6, 2026, and was found to meet the conditions for issuance, listing, and information disclosure [1]. - The final approval from the China Securities Regulatory Commission (CSRC) is still pending, and the timing of this decision remains uncertain [1]. Group 2: Fundraising Allocation - The total investment for the projects funded by the issuance is RMB 87.82 million, with the following allocations: - Expansion of modular ceramic components: Total investment of RMB 60.27 million, with RMB 48.80 million from the fundraising [2]. - Silicon carbide materials and components for semiconductor equipment: Total investment of RMB 6.54 million, with RMB 5.20 million from the fundraising [2]. - Supplementing working capital: Total investment of RMB 21 million, with the entire amount sourced from the fundraising [2]. Group 3: Shareholding Structure - As of September 30, 2025, Liu Xianbing directly holds 192.65 million shares, accounting for 44.19% of the total share capital, and controls an additional 5.53% through other entities, totaling 49.72% control over the company [2].
中信证券保荐牧原股份成功登陆港交所
Xin Lang Cai Jing· 2026-02-06 10:34
来源:市场资讯 | 牧原食品股份有限公司港股上市 | 项目名称 | | | --- | --- | --- | | 牧原股份港股IPO | 项目简称 | | | 2026年2月6日 | 上市日期 | | | 106.84亿港元(超额配售权行使前) | 发行规模 | 122.87亿港元(超额配售权行使后) | | 53.42亿港元 | 基石投资者 投资规模 | | | 保荐人、整体协调人、 | 中信证券角色 | 联席全球协调人、联席账簿管理人 及联席牵头经办人 | 践行农业强国战略 全球生猪养殖龙头开启国际化新纪元 牧原股份是全球第一大生猪养殖企业。本次H股上市, 是牧原股份首次于境外进行股权融资,也是其国际化 战略落地的核心举措。本次发行有助于牧原股份开启 国际化新纪元,推动中国农业现代化技术、管理模式 向全球输出,为我国农牧产业高质量发展与国际竞争 力提升奠定坚实基础 (来源:中信证券发布) 2015年以来香港市场农业板块最大规模IPO 受到境内外投资者广泛关注 本项目是2015年以来香港资本市场农业板块最大规 模IPO。依托对消费行业的深刻理解和全球化投资者 网络覆盖,中信证券协助牧原股份对接并引入国际及 ...
视频 | 大牛股百利天恒预亏11亿元,中信证券给出上千元目标价?
Xin Lang Cai Jing· 2026-02-06 09:55
Group 1 - The article emphasizes the importance of using authoritative and professional analyst reports for stock trading, highlighting their role in identifying potential investment opportunities [1][2] - It mentions that the reports are timely and comprehensive, which aids investors in making informed decisions [1][2] Group 2 - The source of the article is identified as a collaboration with a media partner, indicating that the information is disseminated for the purpose of providing more insights [1][2] - A disclaimer is included, stating that the content is for reference only and does not constitute investment advice, which is a standard practice in financial reporting [1][2]
中国神华1336亿关联收购12公司股权获通过 中信证券建功
Zhong Guo Jing Ji Wang· 2026-02-06 06:51
中国神华昨晚披露的发行股份及支付现金购买资产并募集配套资金暨关联交易报告书(注册稿)显示,本 次交易的独立财务顾问是中信证券。 中国经济网北京2月6日讯中国神华(601088)(601088.SH)昨晚披露了关于发行股份及支付现金购买资 产并募集配套资金暨关联交易事项获得上海证券交易所审核通过的公告。 中国神华拟发行A股股份及支付现金购买控股股东国家能源投资集团有限责任公司持有的国家能源集团 国源电力有限公司100%股权、国家能源集团新疆能源化工有限公司100%股权、中国神华煤制油化工有 限公司100%股权、国家能源集团乌海能源有限责任公司100%股权、内蒙古平庄煤业(集团)有限责任公 司100%股权、国家能源集团陕西神延煤炭有限责任公司41%股权、山西省晋神能源有限公司49%股权、 国家能源集团包头矿业有限责任公司100%股权、国家能源集团航运有限公司100%股权、神华煤炭运销 有限公司100%股权、国家能源集团港口有限公司100%股权,以支付现金的方式购买国家能源集团西部 能源投资有限公司持有的国电建投内蒙古能源有限公司100%股权,并于A股募集配套资金("本次交 易")。 上海证券交易所已于2026年2 ...
黄金持续震荡 还能涨吗?中信证券敖翀:金价上涨趋势并没有完结
2 1 Shi Ji Jing Ji Bao Dao· 2026-02-06 03:20
2026年伊始,黄金行情持续牵动全球投资者的神经。 暴涨——新高——暴跌——回暖——震荡,剧烈的波动之下,市场情绪在狂热与恐慌之间反复切换。有 人止损离场,也有人逢低抄底;也有投资者跑步进场,而后在行情震荡中饱受煎熬…… 截至2月6日11时,国际黄金现货价格约在4850美元/盎司上下,较年初上涨约12%,表现虽超过多数主 流市场指数。然而,与1月29日创下的历史高点相比,金价仍回调超过700美元/盎司。 市场分歧正在加剧。"黄金还能买吗?""该选积存金还是黄金ETF?""这一轮上涨究竟能走多远?"投资 者的疑问纷至沓来。与此同时,已有部分投资者将目光悄然转向其他小金属,试图在金银狂潮之外,提 前捕捉下一个可能起飞的市场。 近日,针对当前黄金市场的剧烈波动与后续走向,21世纪经济报道记者特别对话了中信证券有色金属行 业首席分析师敖翀,试图厘清本轮行情的核心驱动,探寻价格剧烈波动的背后逻辑。 在交流中,敖翀明确指出,当前黄金的上涨趋势尚未完结,流动性预期是当下驱动黄金价格走势的核心 力量。此外,持续的地缘政治冲突也为黄金提供了阶段性的避险动力。 敖翀进一步分析称,随着流动性的持续释放,中国和全球经济有望在未来6- ...
中信证券吴威辰:产业趋势与基本面双轮驱动 固态电池板块步入价值兑现期
Zhong Guo Zheng Quan Bao· 2026-02-06 01:18
Core Viewpoint - The solid-state battery sector is experiencing a transition from a conceptual phase to an industrialization phase, supported by improvements in the fundamentals of related companies and accelerated industry development, indicating strong rationality and sustainability [1][2]. Industry Performance - The solid-state battery index has shown a fluctuation with a year-to-date increase of 12.15% as of January 23, which later adjusted to a 5.52% increase by February 5 [2]. - The strong performance of the sector is attributed to dual support from improved fundamentals and accelerated industry development, moving away from mere thematic speculation [2]. Industry Developments - The release of the draft national standard for solid-state batteries on December 30, 2025, is seen as a milestone that positions China to gain a competitive edge in global industry standards [2]. - Successful vehicle testing of solid-state batteries by companies like Guoxuan High-Tech and FAW Hongqi marks a significant step towards practical application [3]. Technological Advancements - The solid-state battery industry is overcoming technical bottlenecks and is expected to transition from a conceptual phase to a realization phase, indicating long-term investment value [4]. - Key challenges include the maturity of material systems and the production capacity of solid electrolytes, with prices for lithium sulfide expected to drop significantly by 2026 [4][5]. Investment Opportunities - The solid-state battery sector presents a gradient of investment opportunities, with equipment, materials, and battery segments benefiting sequentially from industry development [7]. - Equipment manufacturers are expected to be the first beneficiaries, with significant investments required for specialized equipment, which is projected to yield performance contributions starting in 2026 [7]. - The solid-state battery shipment volume is anticipated to reach 27 GWh by 2027, with a focus on investment opportunities in core areas such as electrode materials and manufacturing processes [8].
中信证券:具备药险资源整合能力与技术壁垒的平台型公司 有望脱颖而出
Mei Ri Jing Ji Xin Wen· 2026-02-06 00:53
(文章来源:每日经济新闻) 中信证券认为,在基本医保管理边界逐渐明晰的趋势下,商保有望成为医疗健康产业支付端的核心增 量,当前政策红利、数据资产与商业健康险产品迭代共振有望开启医疗健康产业多元化支付体系发展新 周期。下一阶段,中信证券认为商保综合服务提供商有望解决保司端人才、数据制约,打开创新药械企 业创新价值兑现面临的结构性瓶颈,进一步助推商业健康险行业边际加速发展。认为伴随商保支付渗透 率提升与数据智能驱动的控费模式成熟,具备药险资源整合能力与技术壁垒的平台型公司,有望脱颖而 出成长为行业龙头。持续建议关注以下三条投资主线:1)平台型公司赋能药险协同,开启支付体系"换 挡升级"新周期。2)创新药械——创新药械有望受益于商业健康险带来的增量支付额以及估值体系提 升;3)民营医疗终端——迎来新支付方,打开未来业绩成长空间。 ...
中信证券:看好存储产能扩张及技术迭代加速 半导体核心供应商空间广阔
Di Yi Cai Jing· 2026-02-06 00:37
(文章来源:第一财经) 中信证券研报表示,受AI强劲需求拉动,判断存储需求将保持高景气度,存储芯片的涨价有望贯穿 2026年全年并持续带来行业催化。看好国内存储大厂的产能扩张和技术迭代加速,晶圆制造工艺相关的 半导体材料用量料将大幅提升,大厂的材料及零部件端核心供应商有望充分受益,随下游产能落地节奏 实现经营数据的阶梯式大幅增长。 ...
已经涨了10倍!中信证券太疯狂,给出百利天恒1322元目标价
Xin Lang Cai Jing· 2026-02-05 23:57
Core Viewpoint - The report from CITIC Securities on January 26, 2023, set a target price of 1322 CNY for Baillie Tianheng (688506.SH), suggesting a potential increase of 367% from its current price of 282.83 CNY, which has drawn significant attention online [1][17]. Group 1: Company Performance and Financials - Baillie Tianheng reported a net loss of 11 billion CNY for 2025, which was a 130% year-on-year decrease in net profit, contradicting CITIC's earlier prediction of a loss of 7.6 billion CNY [17][19]. - The company has experienced substantial research and development expenditures, with figures of 3.75 billion CNY, 7.46 billion CNY, 14.43 billion CNY, and 10.39 billion CNY for the first half of 2025, indicating that R&D costs have significantly outpaced revenue [22][23]. - The company’s revenue for 2022 was 701.83 million CNY, with projections of 560.42 million CNY for 2023 and 5.82 billion CNY for 2024, reflecting a substantial increase in expected revenue [23]. Group 2: Product Development and Market Position - Baillie Tianheng's drug Iza-bren (BL-B01D1) has entered a priority review process for a new indication, which is expected to enhance the company's market position significantly [19][21]. - The company has a total of 17 clinical-stage candidates, with 6 currently undergoing trials in the United States, showcasing its robust pipeline of innovative drugs [21]. - The strategic partnership with BMS, valued at 8.4 billion USD, represents one of the largest global licensing deals in the ADC field, further solidifying Baillie Tianheng's market presence [21]. Group 3: Market Sentiment and Analyst Predictions - The target price of 1322 CNY, which was later removed from the latest report, indicates a highly optimistic outlook from CITIC Securities, despite the company's recent financial struggles [19][20]. - The stock price of Baillie Tianheng has increased over tenfold since its issuance price of 24.7 CNY in January 2023, raising questions about its sustainability at current levels [27]. - Historical context suggests skepticism regarding CITIC's predictions, as similar past forecasts have not materialized positively, such as the case with Moutai [24].